COMMUNIQUÉS West-GlobeNewswire

Yinuo Chen, fondateur de trois grands centres de procréation assistée – Tulip, ONELIFE et Sino – a été invité à participer à la Shanghai Medical Exhibition
29/04/2026
BICHKEK, Kirghizistan, 29 avr. 2026 (GLOBE NEWSWIRE) -- Yinuo Chen, fondateur de trois grands centres de procréation assistée – Tulip (Kirghizistan), ONELIFE (Thaïlande) et Sino (Géorgie) – a été invité à participer à l [...]
EnteroBiotix Secures £19m to Initiate Phase 2b Clinical Trial for Irritable Bowel Syndrome
29/04/2026
Funds will support one of the largest interventional clinical trials of a full-spectrum microbiome product, and the largest ever to be conducted in IBS Dosing of first patient of the Phase 2b ‘RISE’ trial anticipated in [...]
Enlitic Announces Full Integration with Sectra, Expanding Access for Sectra Customers
29/04/2026
LOVELAND, Colo., April 29, 2026 (GLOBE NEWSWIRE) -- Enlitic today announced the completion of its integration with Sectra, enabling Enlitic to support Sectra customers directly with its Ensight platform. The integration [...]
Angelini Ventures Invests in Hypervision Surgical’s £17 Million Series A to Advance Real-time Hyperspectral Imaging and Improve Clinical Outcomes in Surgery
29/04/2026
Funding will support commercial deployment, clinical adoption and further development and enhancement of the Hyperspectral Intelligence® platform for AI-assisted surgery Angelini Ventures Managing Director Tanja Dowe [...]
AB Science announces the successful completion of a EUR 3.2 million private placement
29/04/2026
PRESS RELEASE AB SCIENCE ANNOUNCES THE SUCCESSFUL COMPLETION OF A EUR 3.2 MILLION PRIVATE PLACEMENT Paris, April 29, 2026, 8am AB Science S.A. (the “ Company ” or “ AB Science ”, Euronext – FR0010557264 – AB) announces [...]
AB Science annonce le succès d’un placement prive de 3,2 millions d’euros
29/04/2026
COMMUNIQUE DE PRESSE AB SCIENCE ANNONCE LE SUCCES D’UN PLACEMENT PRIVE DE 3,2 MILLIONS D’EUROS Paris, 29 avril 2026, 8h AB Science S.A. (la “ Société ” ou “ AB Science ”, Euronext – FR0010557264 – AB) annonce aujourd' [...]
Purespring announces publication of notable study highlighting an under recognised genetic driver of adult-onset FSGS, in particular in US and UK populations
29/04/2026
Population modelling study published in Kidney International Reports Analysis of over 1.2 million genomes from five international databases predicts a substantial, previously underdiagnosed adult NPHS2-FSGS population [...]
Phonak Virto ™ R Infinio Earns 2026 Red Dot Award for Product Design
29/04/2026
Recognition highlights precision-crafted customization and next-generation performance in a compact, in-the-ear hearing solution STÄFA, Switzerland, April 29, 2026 (GLOBE NEWSWIRE) -- Phonak, a global leader in [...]
Addex GABAB PAM Candidate Demonstrates Solid Anti-Tussive Activity in Bleomycin IPF-Related Chronic Cough Model
29/04/2026
Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, April 29, 2026 - Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel [...]
Mesoblast Achieves Patient Recruitment Target in Pivotal Phase 3 Trial for Chronic Low Back Pain
29/04/2026
NEW YORK, April 28, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that its pivotal Phase 3 clinical trial [...]
InnoCare Announces First Patient Dosed in Phase III Trial of Orelabrutinib for SLE
29/04/2026
BEIJING, April 28, 2026 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 9969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that the first [...]
Oruka Therapeutics Announces Pricing of Upsized $700 Million Underwritten Public Offering
29/04/2026
MENLO PARK, Calif., April 28, 2026 (GLOBE NEWSWIRE) -- Oruka Therapeutics, Inc. (Nasdaq: ORKA), a clinical-stage biopharmaceutical company focused on developing novel monoclonal antibody therapeutics for psoriasis and [...]
ARCPOINT ANNOUNCES RESIGNATION OF BOARD MEMBER
29/04/2026
Greenville, South Carolina, April 28, 2026 (GLOBE NEWSWIRE) -- ARCpoint Inc. (TSXV: ARC) (the “ Company ” or “ ARCpoint ”) reports that Felix Mirando has resigned as a member of the Company’s Board of Directors for [...]
Glass House Brands Announces Warrant Redemption Notice
28/04/2026
LONG BEACH, Calif. and TORONTO, April 28, 2026 (GLOBE NEWSWIRE) -- Glass House Brands Inc. ("Glass House") (CBOE CA: GLAS.A.U) (CBOE CA: GLAS.WT.U) (OTCQX: GLASF) (OTCQX: GHBWF) today announced that it has delivered a [...]
Glass House Brands Reports Preliminary Unaudited First Quarter Financial Results, Updates FY2026 Guidance and Schedules Earnings Conference Call
28/04/2026
LONG BEACH, Calif. and TORONTO, April 28, 2026 (GLOBE NEWSWIRE) -- Glass House Brands Inc. ("Glass House") (CBOE CA: GLAS.A.U) (CBOE CA: GLAS.WT.U) (OTCQX: GLASF) (OTCQX: GHBWF) today announced preliminary and unaudited [...]
ASAP Dental Care Sets New Benchmark in Clinical Excellence with Over 229,000 Successful Procedures Performed
28/04/2026
North Florida's Leading Dental Provider Offers an Increased Number of Procedures Across All Locations Jacksonville, FL, April 28, 2026 (GLOBE NEWSWIRE) -- ASAP Dental Care, a cornerstone of the Jacksonville healthcare [...]
Organogenesis Completes Rolling Submission of Biologics License Application for ReNu®
28/04/2026
If approved, ReNu® will revolutionize treatment options for millions of patients with knee OA pain CANTON, Mass., April 28, 2026 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative [...]
Pacira BioSciences Files Definitive Proxy Materials and Mails Letter to Shareholders
28/04/2026
Urges Stockholders to Vote “FOR” Pacira’s Highly Qualified Nominees on the BLUE Proxy Card Today Strongly Opposes the Election of Each of DOMA’s Underqualified Nominees BRISBANE, Calif., April 28, 2026 (GLOBE NEWSWIRE [...]
Bioventus to Report First Quarter of Fiscal Year 2026 Financial Results on May 6, 2026
28/04/2026
DURHAM, N.C., April 28, 2026 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will report financial results for [...]

Pages